Impact of proteogenomic evidence on clinical success
Karim, M. A.; Hukku, A.; Ariano, B.; Holzinger, E.; Tsepilov, Y.; Hayhurst, J.; Buniello, A.; McDonagh, E. M.; Castel, S. E.; Nelson, M. R.; Maranville, J.; Yerges-Armstrong, L.; Ghoussaini, M.
Show abstract
We assessed the impact of plasma protein quantitative trait loci (pQTL) on therapeutic hypotheses backed by human genetic evidence. We show that pQTL-supported target-indication pairs were 4.7 times more likely to advance from Phase I to launch, compared to a 2.6-fold increase observed only with human genetic evidence. Moreover, pQTL-based enrichment was prominent in druggable protein families which had limited enrichment from human genetic evidence alone.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.